CN Patent

CN107624067A — 用于治疗异常不自主运动障碍的方法

Assigned to Auspex Pharmaceuticals Inc · Expires 2018-01-23 · 8y expired

What this patent protects

本申请公开了用于氘取代的苯并喹啉化合物的新给药方案，以及用于治疗异常肌肉活动、运动障碍和相关病症的方法。

USPTO Abstract

本申请公开了用于氘取代的苯并喹啉化合物的新给药方案，以及用于治疗异常肌肉活动、运动障碍和相关病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN107624067A
Jurisdiction
CN
Classification
—
Expires
2018-01-23
Drug substance claim
No
Drug product claim
No
Assignee
Auspex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.